| ALLO Shares Outstanding History Table | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Below is a table of the ALLO shares outstanding history going back to 10/11/2018:
Also see: ALLO Market Cap History ALLO YTD Return |
ALLO Shares Outstanding History — Allogene Therapeutics Share Count Over Time
As of 8/10/2026 Allogene Therapeutics has 345.49 million ALLO shares outstanding. Investors often track the ALLO shares outstanding history to compare shareholder return trends against the change in share count over time.
This page shows ALLO share count trends over time, with 32 historical shares outstanding datapoints presented, dating back to 10/11/2018.
| ALLO Shares Outstanding History Chart | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
ALLO Historical Shares Outstanding: +15.24% CAGR 
Mouse over chart for data details
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| ALLO Stock Price Chart |
| About Allogene Therapeutics Inc |
| Allogene Therapeutics, Inc. is a clinical-stage immuno-oncology company. Co. is focused on development of genetically engineered allogeneic T cell product candidates for the treatment of cancer and autoimmune diseases. It is focused on four core programs: Large B-Cell Lymphoma (LBCL), Chronic Lymphocytic Leukemia (CLL), Autoimmune Disease and Renal Cell Carcinoma. It is developing a pipeline of multiple allogeneic chimeric antigen receptor (CAR) T cell product candidates utilizing protein engineering, gene editing, gene insertion and advanced proprietary T cell manufacturing technologies. We show 32 historical shares outstanding datapoints in our coverage of ALLO's shares outstanding history. Understanding the changing numbers of ALLO shares outstanding — and comprehending the concept of differing number of shares outstanding in general comparing companies like ALLO versus peers — is critical for investors. Many "beginner" or "novice" investors will look at one stock trading at a price of $10 per share and another trading at a price of $20 per share and think the latter company is worth twice as much. Of course, that is a completely meaningless comparison without also knowing how many shares outstanding there are for each of the two companies. Furthermore, via issuance of new shares over time, or the repurchase of existing shares, the number of shares outstanding can fluctuate over the course of history. With this page we aim to empower investors researching ALLO by allowing them to research ALLO shares outstanding history as well as any other stock in our coverage universe. |
| ALLO Current Stock Quote |
Quotes delayed 20 minutes  Free ALLO Email Alerts:
Get Dividend Alerts 
Get SEC Filing Alerts
|
| Video: Shares Outstanding Importance | |
|
Video: Shares Outstanding Importance
| ALLO Share Performance |
| Shares Outstanding Peers |
| Allogene Therapeutics (ALLO) is categorized under the Healthcare sector; to help you further research historical shares outstanding numbers, below are some other companies in the same sector:
ALLR Shares Outstanding History ALMS Shares Outstanding History ALNA Shares Outstanding History ALNY Shares Outstanding History ALOG Shares Outstanding History ALPN Shares Outstanding History ALQA Shares Outstanding History ALRN Shares Outstanding History ALT Shares Outstanding History ALTS Shares Outstanding History More Healthcare companies » |
ALLO Shares Outstanding History | www.SharesOutstandingHistory.com | Copyright © 2017 - 2026, All Rights Reserved
Nothing in SharesOutstandingHistory.com is intended to be investment advice, nor does it represent the opinion of, counsel
from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners.
None of the information contained herein constitutes a recommendation that any particular security, portfolio,
transaction, or investment strategy is suitable for any specific person. All viewers agree that under no
circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held
liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you
agree to the following Full Disclaimer & Terms of Use and
Privacy Policy. Video widget and market videos powered by Market News Video. Quote and option data delayed at
least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.
